The groundbreaking rise of Viagra has long been a symbol of pharmaceutical success, however its future within the broader sector now triggers questions about future returns . Copycat versions are undercutting patent protection , leading to concerns that betting on companies heavily reliant to Viagra's once-dominant position could be a dangerous str